Pure Global AI
Disease / condition

Hepatitis C clinical trials

Free access to 561 studies10+ countriesUpdated daily32 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
561
Total trials
10+
Countries
10+
Sponsors
32
Recruiting
By phase
N/A217
Phase 192
Phase 376
Phase 276
Phase 463
By status
Completed370
Unknown53
Terminated37
Recruiting32
Withdrawn27
Top countries
United States of America138
Egypt25
Australia22
Japan21
Puerto Rico,United States of America18
Top sponsors
Bristol-Myers Squi...44
Merck Sharp & Dohm...41
Gilead Sciences18
Vertex Pharmaceuti...15
Kirby Institute13
Recent trials
Latest clinical trials for Hepatitis C
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
Oregon Health and Science Univ...
NCT06409169Not yet recr...
Hepatitis C Lab Testing Comparison Study
HealthPartners Institute
NCT06380166Not yet recr...
Trial of Hepatitis C Self-Testing in the Hands of Untrained Lay Users
bioLytical Laboratories · South Africa
NCT06369116Recruiting
INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation
bioLytical Laboratories · Canada
NCT06357819Completed
Re-link HCV in Substance-Use Telemedicine Program
trueNorth Medical Centres · Canada
NCT06349902Recruiting
Safety and Efficacy of Decentralized HCV Treatment vs Standard-of-Care in Rio de Janeiro (Brazil)
Oswaldo Cruz Foundation · Brazil
NCT06306300Recruiting
Phase
Phase 4
HCV Tappt Adherence Study
University of Illinois at Chic...
NCT06263829Not yet recr...
HCV Microfluidic Diagnostics
University of Hull · United Kingdom
NCT06047275Recruitment ...
A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX
Cerrahpasa Medical Faculty Fou... · Turkey
NCT06010524Recruiting
The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset
Kirby Institute
NCT05713136Not yet recr...
MOTIVATE-C: a randomised trial to evaluate the impact of financial incentives on the rate of initiation of antiviral therapy in people with hepatitis C
The University of Sydney · Australia
ANZCTR12623000024640Recruiting
Phase
Not Applicable
Hepatitis C Diagnosis to Treatment Management
Epividian · United States of America
NCT05725109Enrolling by...
Hepatitis C Screening Alerts
Epividian · United States of America
NCT05710120Enrolling by...
Effectiveness of awareness-raising activities through care managers regarding hepatitis C screening and treatment among elderly persons requiring support and nursing care and their families.
Saga University · Japan
UMIN000049406Not yet recr...
Phase
Not Applicable
HCV Test and Treat Utilizing Simplified HCV Patient Education
Weill Medical College of Corne... · United States of America
NCT05582681Recruiting
Phase
Phase 4
Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy.
Tanta University
NCT05465434Not yet recr...
Phase
Phase 3
Plasma MicroRNA for Prediction of Hepatocellular Carcinoma
Benha University · Egypt
NCT05449847Completed
Treatment of Hepatitis c by Using Direct-acting Antiviral
Tanta University
NCT05372874Not yet recr...
EPIC: Evaluation of Pharmacy-based Identification and Treatment of HCV
Cool Aid Community Health Cent... · Canada
NCT05412017Recruiting
The Treatment in Pregnancy for Hepatitis C (TiP-HepC) Registry
The Task Force for Global Heal... · United States of America
NCT05368974Recruiting
About this profile

Access comprehensive clinical trial information for Hepatitis C through Pure Global AI's free database. This collection includes 561 clinical trials across multiple phases including N/A, Phase 1, Phase 3. Currently, 32 trials are actively recruiting participants.

Research for Hepatitis C is being conducted in United States of America, Egypt, Australia and 7+ other countries. Leading sponsors include Bristol-Myers Squibb and Merck Sharp & Dohme LLC. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 561 clinical trials studying Hepatitis C, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Bristol-Myers Squibb, Merck Sharp & Dohme LLC, Gilead Sciences, among others.